Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up von Hochhaus, A., Saussele, S., Rosti, G., Mahon, F.-X., Janssen, J.J.W.M., Hjorth-Hansen, H., Richter, J., Buske, C.

Volltext

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia von Hochhaus, A., Baccarani, M., Silver, R. T., Schiffer, C., Apperley, J. F., Cervantes, F., Clark, R. E., Cortes, J. E., Deininger, M. W., Guilhot, F., Hjorth-Hansen, H., Hughes, T. P., Janssen, J. J. W. M., Kantarjian, H. M., Kim, D. W., Larson, R. A., Lipton, J. H., Mahon, F. X., Mayer, J., Nicolini, F., Niederwieser, D., Pane, F., Radich, J. P., Rea, D., Richter, J., Rosti, G., Rousselot, P., Saglio, G., Saußele, S., Soverini, S., Steegmann, J. L., Turkina, A., Zaritskey, A., Hehlmann, R.

Volltext

European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia von Steegmann, J L, Baccarani, M, Breccia, M, Casado, L F, García-Gutiérrez, V, Hochhaus, A, Kim, D-W, Kim, T D, Khoury, H J, Le Coutre, P, Mayer, J, Milojkovic, D, Porkka, K, Rea, D, Rosti, G, Saussele, S, Hehlmann, R, Clark, R E

Volltext

Treatment and outcome of 2904 CML patients from the EUTOS population-based registry von Hoffmann, V S, Baccarani, M, Hasford, J, Castagnetti, F, Di Raimondo, F, Casado, L F, Turkina, A, Zackova, D, Ossenkoppele, G, Zaritskey, A, Höglund, M, Simonsson, B, Indrak, K, Sninska, Z, Sacha, T, Clark, R, Bogdanovic, A, Hellmann, A, Griskevicius, L, Schubert-Fritschle, G, Sertic, D, Guilhot, J, Lejniece, S, Zupan, I, Burgstaller, S, Koskenvesa, P, Everaus, H, Costeas, P, Lindoerfer, D, Rosti, G, Saussele, S, Hochhaus, A, Hehlmann, R

Volltext

Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study von Hochhaus, A, Rosti, G, Cross, N C P, Steegmann, J L, le Coutre, P, Ossenkoppele, G, Petrov, L, Masszi, T, Hellmann, A, Griskevicius, L, Wiktor-Jedrzejczak, W, Rea, D, Coriu, D, Brümmendorf, T H, Porkka, K, Saglio, G, Gastl, G, Müller, M C, Schuld, P, Di Matteo, P, Pellegrino, A, Dezzani, L, Mahon, F-X, Baccarani, M, Giles, F J

Volltext

Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinib von Kim, T D, Rea, D, Schwarz, M, Grille, P, Nicolini, F E, Rosti, G, Levato, L, Giles, F J, Dombret, H, Mirault, T, Labussière, H, Lindhorst, R, Haverkamp, W, Buschmann, I, Dörken, B, le Coutre, P D

Volltext

Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib von Castagnetti, F, Gugliotta, G, Breccia, M, Stagno, F, Iurlo, A, Albano, F, Abruzzese, E, Martino, B, Levato, L, Intermesoli, T, Pregno, P, Rossi, G, Gherlinzoni, F, Leoni, P, Cavazzini, F, Venturi, C, Soverini, S, Testoni, N, Alimena, G, Cavo, M, Martinelli, G, Pane, F, Saglio, G, Rosti, G, Baccarani, M

Volltext

Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study von Iurlo, A, Cattaneo, D, Consonni, D, Castagnetti, F, Miggiano, M C, Binotto, G, Bonifacio, M, Rege-Cambrin, G, Tiribelli, M, Lunghi, F, Gozzini, A, Pregno, P, Abruzzese, E, Capodanno, I, Bucelli, C, Pizzuti, M, Artuso, S, Iezza, M, Scalzulli, E, La Barba, G, Maggi, A, Russo, S, Elena, C, Scortechini, A R, Tafuri, A, Latagliata, R, Caocci, G, Bocchia, M, Galimberti, S, Luciano, L, Fava, C, Foà, R, Saglio, G, Rosti, G, Breccia, M

Volltext

Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors von Mancini, M, De Santis, S, Monaldi, C, Bavaro, L, Martelli, M, Castagnetti, F, Gugliotta, G, Rosti, G, Santucci, M A, Martinelli, G, Cavo, M, Soverini, S

Volltext

Investigating factors associated with adherence behaviour in patients with chronic myeloid leukemia: an observational patient-centered outcome study von Efficace, F, Baccarani, M, Rosti, G, Cottone, F, Castagnetti, F, Breccia, M, Alimena, G, Iurlo, A, Rossi, A R, Pardini, S, Gherlinzoni, F, Salvucci, M, Tiribelli, M, Vignetti, M, Mandelli, F

Volltext

Nilotinib is active in chronic and accelerated phase chronic myeloid leukemia following failure of imatinib and dasatinib therapy von Giles, F J, Abruzzese, E, Rosti, G, Kim, D-W, Bhatia, R, Bosly, A, Goldberg, S, Kam, G L S, Jagasia, M, Mendrek, W, Fischer, T, Facon, T, Dünzinger, U, Marin, D, Mueller, M C, Shou, Y, Gallagher, N J, Larson, R A, Mahon, F-X, Baccarani, M, Cortes, J, Kantarjian, H M

Volltext

Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinib von Efficace, F, Baccarani, M, Breccia, M, Cottone, F, Alimena, G, Deliliers, G L, Baratè, C, Specchia, G, Di Lorenzo, R, Luciano, L, Turri, D, Martino, B, Stagno, F, Dabusti, M, Bergamaschi, M, Leoni, P, Simula, M P, Levato, L, Fava, C, Veneri, D, Sica, S, Rambaldi, A, Rosti, G, Vignetti, M, Mandelli, F

Volltext

Nilotinib 300 mg twice daily: an academic single-arm study of newly diagnosed chronic phase chronic myeloid leukemia patients von Castagnetti, Fausto, Breccia, Massimo, Gugliotta, Gabriele, Martino, Bruno, D'Adda, Mariella, Stagno, Fabio, Carella, Angelo Michele, Avanzini, Paolo, Tiribelli, Mario, Trabacchi, Elena, Visani, Giuseppe, Gobbi, Marco, Salvucci, Marzia, Levato, Luciano, Binotto, Gianni, Capalbo, Silvana Franca, Bochicchio, Maria Teresa, Soverini, Simona, Cavo, Michele, Martinelli, Giovanni, Alimena, Giuliana, Pane, Fabrizio, Saglio, Giuseppe, Rosti, Gianantonio, Baccarani, Michele

Volltext

Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer von Oldenburg, J., Aparicio, J., Beyer, J., Cohn-Cedermark, G., Cullen, M., Gilligan, T., De Giorgi, U., De Santis, M., de Wit, R., Fosså, S.D., Germà-Lluch, J.R., Gillessen, S., Haugnes, H.S., Honecker, F., Horwich, A., Lorch, A., Ondruš, D., Rosti, G., Stephenson, A.J., Tandstad, T.

Volltext

The EUTOS prognostic score: review and validation in 1288 patients with CML treated frontline with imatinib von Hoffmann, V S, Baccarani, M, Lindoerfer, D, Castagnetti, F, Turkina, A, Zaritsky, A, Hellmann, A, Prejzner, W, Steegmann, J-L, Mayer, J, Indrak, K, Colita, A, Rosti, G, Pfirrmann, M

Volltext

Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain von Soverini, Simona, Colarossi, Sabrina, Gnani, Alessandra, Castagnetti, Fausto, Rosti, Gianantonio, Bosi, Costanza, Paolini, Stefania, Rondoni, Michela, Piccaluga, Pier Paolo, Palandri, Francesca, Giannoulia, Panagiota, Marzocchi, Giulia, Luatti, Simona, Testoni, Nicoletta, Iacobucci, Ilaria, Cilloni, Daniela, Saglio, Giuseppe, Baccarani, Michele, Martinelli, Giovanni

Volltext

Corrections to “Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up” von Hochhaus, A., Saussele, S., Rosti, G., Mahon, F.-X., Janssen, J.J.W.M, Hjorth-Hansen, H., Richter, J., Buske, C.

Volltext

Cost-Consequence Analysis of an Aprepitant Regimen Versus a Standard Antiemetic Regimen for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting in Italy von Rosti, G, Ravasio, R

Volltext

Salvage high-dose chemotherapy in female patients with relapsed/refractory germ-cell tumors: a retrospective analysis of the European Group for Blood and Marrow Transplantation (EB... von De Giorgi, U., Richard, S., Badoglio, M., Kanfer, E., Bourrhis, J.H., Nicolas-Virelizier, E., Vettenranta, K., Lioure, B., Martin, S., Dreger, P., Schuler, M.K., Thomson, K., Scarpi, E., Rosti, G., Selle, F., Mangili, G., Lanza, F., Bregni, M.

Volltext

European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG) von Schmoll, H. J., Souchon, R., Krege, S., Albers, P., Beyer, J., Kollmannsberger, C., Fossa, S. D., Skakkebaek, N. E., de Wit, R., Fizazi, K., Droz, J. P., Pizzocaro, G., Daugaard, G., de Mulder, P. H. M., Horwich, A., Oliver, T., Huddart, R., Rosti, G., Paz Ares, L., Pont, O., Hartmann, J. T., Aass, N., Algaba, F., Bamberg, M., Bodrogi, I., Bokemeyer, C., Classen, J., Clemm, S., Culine, S., de Wit, M., Derigs, H. G., Dieckmann, K. P., Flasshove, M., Garcia del Muro, X., Gerl, A., Germa-Lluch, J. R., Hartmann, M., Heidenreich, A., Hoeltl, W., Joffe, J., Jones, W., Kaiser, G., Klepp, O., Kliesch, S., Kisbenedek, L., Koehrmann, K. U., Kuczyk, M., Laguna, M. P., Leiva, O., Loy, V., Mason, M. D., Mead, G. M., Mueller, R. P., Nicolai, N., Oosterhof, G. O. N., Pottek, T., Rick, O., Schmidberger, H., Sedlmayer, F., Siegert, W., Studer, U., Tjulandin, S., von der Maase, H., Walz, P., Weinknecht, S., Weissbach, L., Winter, E., Wittekind, C.

Volltext